EU Plans to Block Russians From Buying European Real Estate
(Bloomberg) --
The European Union added a ban on property transactions with Russian nationals to its sixth package of sanctions designed to raise pressure on Vladimir Putin.
The European Commission's proposal would halt property deals with Russian citizens, residents and entities -- prohibiting the sale or transfer, directly or indirectly, of “ownership rights in immovable property located within the territory of the Union or units in collective investment undertakings providing exposure to such immovable property,” according to the legal text seen by Bloomberg News.
The ban is part of the EU's latest move to hit the Russian state and oligarchs, measures that will for the first time target Moscow's lucrative oil industry and Sberbank, the country's largest bank. The plan needs to be endorsed by EU member states this week before entering into force -- and may be subject to change.
The prohibition applies to Russians who are not EU citizens and lack a residency permit in EU member states. It doesn't apply to those who carry citizenship or residency in the European Economic Area or Switzerland.
Many Russian billionaires have acquired property in the EU since the collapse of the Soviet Union as they shifted some or most of their wealth outside their homeland. Roman Abramovich owns a 26,000 square-foot chateau in France with a rooftop pool, while Suleiman Kerimov has been linked to the high-end property in the nation with a tennis court and giant oval outdoor pool.
The EU has already taken tough action along with the U.S. and U.K. over other luxury assets for Russia's ultra-wealthy. More than a dozen superyachts have been impounded or seized in European ports since the start of the war in Ukraine as part of sanctions efforts leveled at Russian billionaires.
One of the largest and most expensive of the detained vessels is Dilbar, a 156-meter (512-foot) motor yacht owned by Alisher Usmanov, who has been sanctioned by the U.S., U.K. and EU.
©2022 Bloomberg L.P.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.